文献速递妇科生殖医学

活性维生素D对子宫内膜异位症间质细胞增殖、细胞周期和凋亡的影响

Effect of active vitamin D on proliferation, cell cycle and apoptosis in endometriotic stromal cells.
PubMed 文献 · Reprod Biomed Online · 2022-11-18

研究从10例子宫内膜异位症患者和10例健康对照分离子宫内膜间质细胞,用1,25(OH)2D3处理,72小时后检测增殖、细胞周期和凋亡。在有雌激素时,1,25(OH)2D3抑制三种来源间质细胞增殖(CESC P=0.009,EuESC P=0.005,EESC P<0.001),并抑制所有类型细胞周期;无雌激素时仅抑制EuESC细胞周期(P=0.012)。1,25(OH)2D3增加EuESC和EESC的凋亡和坏死细胞、减少活细胞,对CESC不影响凋亡仅增加坏死细胞。

要点

  • 有雌激素时1,25(OH)2D3抑制CESC、EuESC和EESC增殖,P值分别为0.009、0.005和<0.001。
  • EESC的S期细胞比例高于EuESC和CESC(P=0.002和P=0.001),EuESC高于CESC(P=0.005)。
  • 1,25(OH)2D3增加EuESC和EESC的凋亡和坏死细胞、减少活细胞,对CESC仅增加坏死细胞。

核心结论

  • 1,25(OH)2D3对子宫内膜异位症患者的间质细胞可能具有生长抑制和促凋亡作用。

研究设计与样本

  • 从10例子宫内膜异位症女性和10例健康对照分离子宫内膜间质细胞,用1,25(OH)2D3处理。
  • 处理72小时后用甲基噻唑基四唑盐法分析CESC、EuESC和EESC的增殖。
  • 用碘化丙啶染色和流式细胞术测定细胞周期分布,用膜联蛋白V/碘化丙啶双染评估凋亡。

主要发现

  • 有雌激素时,1,25(OH)2D3抑制三种来源间质细胞增殖(CESC P=0.009,EuESC P=0.005,EESC P<0.001)。
  • EESC的S期细胞比例高于EuESC和CESC(P=0.002和P=0.001),EuESC高于CESC(P=0.005)。
  • EESC的G1期细胞比例低于EuESC和CESC(P=0.003和P=0.002),EuESC低于CESC(P=0.007)。
  • 1,25(OH)2D3抑制细胞周期:EESC P=0.002,EuESC P=0.001,CESC P=0.014;无雌激素时仅抑制EuESC细胞周期(P=0.012)。
  • 1,25(OH)2D3增加EuESC和EESC的凋亡和坏死细胞、减少活细胞,对CESC不影响凋亡仅增加坏死细胞。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: What is the effect of vitamin D3 (1,25(OH)2D3) on proliferation, cell cycle and apoptosis of endometrial stromal cells (ESC) in endometriotic patients? DESIGN: ESC isolated from 10 women with endometriosis and 10 healthy controls were treated with 1,25(OH)2D3. The proliferation of control endometrial stromal cells (CESC), eutopic endometrial stromal cells (EuESC) and ectopic endometrial stromal cells (EESC) was analysed 72 h after the treatment using methyl thiazolyl tetrazolium assay. Propidium iodide staining and flow cytometry were used to determine the cell cycle distribution in ESC. Annexin V/propidium iodide double staining was used to evaluate apoptosis in ESC. RESULTS: In the presence of oestrogen, 1,25(OH)2D3 treatment inhibited the proliferation of ESC from all three origins (P = 0.009 for CESC, P = 0.005 for EuESC and P < 0.001 for EESC). The percentage of S phase cells in EESC was higher than in EuESC and CESC (P = 0.002 and P = 0.001, respectively). The percentage of S phase cells in EuESC was higher than in CESC (P = 0.005). The percentage of G1 phase cells in EESC was lower than that of EuESC and CESC (P = 0.003 and P = 0.002, respectively) and the percentage of G1 phase cells in EuESC was lower than that of CESC (P = 0.007). Moreover, 1,25(OH)2D3 inhibited cell cycle regardless of cell type (P = 0.002 in EESC, P = 0.001 in EuESC and P = 0.014 in CESC), but in the absence of oestrogen, inhibited cell cycle only in EuESC (P = 0.012). CONCLUSIONS: Although 1,25(OH)2D3 increased apoptotic and necrotic cells and decreased live cells in the EuESC and EESC, it did not affect apoptosis in CESC and only increased necrotic cells. These findings indicate that 1,25(OH)2D3 potentially has a growth-inhibiting and pro-apoptotic effect on ESC from endometriotic patients.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Rashidi N, Arefi S, Sadri M, et al. Effect of active vitamin D on proliferation, cell cycle and apoptosis in endometriotic stromal cells. Reprod Biomed Online. 2022. PMID: 36588053. doi:10.1016/j.rbmo.2022.11.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。